CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present invention relates to peptidomimetics capable of inhibiting CD28 and/or CTLA-4 interaction with CD80 (B7-1) and CD86 (B7-2) and having a core amino acid sequence, LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The present invention also relates to pharmaceutica...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | EL TAYAR, NABIL JAMESON, BRAD BLECHNER, STEVEN TEPPER, MARK |
| description | The present invention relates to peptidomimetics capable of inhibiting CD28 and/or CTLA-4 interaction with CD80 (B7-1) and CD86 (B7-2) and having a core amino acid sequence, LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The present invention also relates to pharmaceutical compositions and a method of treating pathologies and disorders which are improved by inhibition of CD28 and/or CTLA-4 interaction with CD80 and CD86. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0989858A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0989858A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0989858A13</originalsourceid><addsrcrecordid>eNqNyksKwjAQgOFsXIh6h7lA8Q3pckymZqB50IzrUiSuRAv1_tiFB3D1w8-3VMHYg94aabE6AQfHFxYOV0iUhG307EnYZMBgITnsPBq6zQdbMNGnmGceQwZx1FFs1mrxGJ5T2fy6UtCQGFeV8d2XaRzu5VU-PaVdrWt91rg__kG-qvYuPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF</title><source>esp@cenet</source><creator>EL TAYAR, NABIL ; JAMESON, BRAD ; BLECHNER, STEVEN ; TEPPER, MARK</creator><creatorcontrib>EL TAYAR, NABIL ; JAMESON, BRAD ; BLECHNER, STEVEN ; TEPPER, MARK</creatorcontrib><description>The present invention relates to peptidomimetics capable of inhibiting CD28 and/or CTLA-4 interaction with CD80 (B7-1) and CD86 (B7-2) and having a core amino acid sequence, LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The present invention also relates to pharmaceutical compositions and a method of treating pathologies and disorders which are improved by inhibition of CD28 and/or CTLA-4 interaction with CD80 and CD86.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000405&DB=EPODOC&CC=EP&NR=0989858A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000405&DB=EPODOC&CC=EP&NR=0989858A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EL TAYAR, NABIL</creatorcontrib><creatorcontrib>JAMESON, BRAD</creatorcontrib><creatorcontrib>BLECHNER, STEVEN</creatorcontrib><creatorcontrib>TEPPER, MARK</creatorcontrib><title>CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF</title><description>The present invention relates to peptidomimetics capable of inhibiting CD28 and/or CTLA-4 interaction with CD80 (B7-1) and CD86 (B7-2) and having a core amino acid sequence, LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The present invention also relates to pharmaceutical compositions and a method of treating pathologies and disorders which are improved by inhibition of CD28 and/or CTLA-4 interaction with CD80 and CD86.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyksKwjAQgOFsXIh6h7lA8Q3pckymZqB50IzrUiSuRAv1_tiFB3D1w8-3VMHYg94aabE6AQfHFxYOV0iUhG307EnYZMBgITnsPBq6zQdbMNGnmGceQwZx1FFs1mrxGJ5T2fy6UtCQGFeV8d2XaRzu5VU-PaVdrWt91rg__kG-qvYuPw</recordid><startdate>20000405</startdate><enddate>20000405</enddate><creator>EL TAYAR, NABIL</creator><creator>JAMESON, BRAD</creator><creator>BLECHNER, STEVEN</creator><creator>TEPPER, MARK</creator><scope>EVB</scope></search><sort><creationdate>20000405</creationdate><title>CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF</title><author>EL TAYAR, NABIL ; JAMESON, BRAD ; BLECHNER, STEVEN ; TEPPER, MARK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0989858A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2000</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>EL TAYAR, NABIL</creatorcontrib><creatorcontrib>JAMESON, BRAD</creatorcontrib><creatorcontrib>BLECHNER, STEVEN</creatorcontrib><creatorcontrib>TEPPER, MARK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EL TAYAR, NABIL</au><au>JAMESON, BRAD</au><au>BLECHNER, STEVEN</au><au>TEPPER, MARK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF</title><date>2000-04-05</date><risdate>2000</risdate><abstract>The present invention relates to peptidomimetics capable of inhibiting CD28 and/or CTLA-4 interaction with CD80 (B7-1) and CD86 (B7-2) and having a core amino acid sequence, LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The present invention also relates to pharmaceutical compositions and a method of treating pathologies and disorders which are improved by inhibition of CD28 and/or CTLA-4 interaction with CD80 and CD86.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP0989858A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A02%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EL%20TAYAR,%20NABIL&rft.date=2000-04-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0989858A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |